EFEkaterina V. Freydlin

Ekaterina V. Freydlin

*This is an algorithmically generated author record based on publicly available information.

Ekaterina V. Freydlin has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cytokine levels in coprofiltrates in children with inflammatory bowel disease

    by Anastasia Е. Krasnovidova, Elena L. Semikina, Alexander S. Potapov, Anna P. Toptygina, Olga V. Kurbatova, Tatiana V. Radygina, Ekaterina V. Freydlin, Kadria A. Mokretsova

    Background. The key role in the pathogenesis of inflammatory bowel disease (IBD) is an imbalance between pro- and anti-inflammatory cytokines. Numerous studies confirm that serum levels of certain cytokines correlate with disease activity in ulcerative colitis (UC) and Crohn's disease (CD). Non-invasive assessment of fecal cytokine concentrations, which reflect the local inflammatory process, is an underexplored but promising diagnostic approach. Aim. The aim of the study is to determine the diagnostic significance of cytokine profile for disease activity assessing in pediatric IBD. Materials and methods. This clinical, bidirectional, observational study included 143 children with a verified diagnosis of UC (n=75) and CD (n=68). Disease activity was assessed using the pediatric activity indices for UC and CD, the UC Endoscopic Index of Severity, and the Simple Endoscopic Score for CD. Clinical and biochemical blood tests were performed, and fecal calprotectin levels were measured. Concentrations of cytokines Interleukin IL-1α, 1RA, 7, 9, 10, 15, 17A, 21, 22, 23, 27, 31, Interferon α and Tumor Necrosis Factor β in aqueous-salt coprofiltrates were determined using a multiplex immunoassay panel. Results. Pro-inflammatory cytokines IL-1α, 17A, 23, 31, TNF-β in UC, and IL-1α, 23, 31, TNF-β in CD, reflect clinical disease activity. In both UC and CD cytokines IL-1α, 23, TNF-β reflect the severity of the endoscopic picture. Anti-inflammatory cytokines IL-10 and IL-22 reflect reparative processes in the intestinal mucosa in CD, whereas in UC, only IL-22 does. A decrease in endoscopic activity is reflected by IL-10 and IL-22 levels in UC and by IL-22 in CD. No association was found between cytokine concentration in coprofiltrate and the extent of UC or the localization of CD. Conclusion. From the spectrum of cytokines we studied, a number of pro- and anti-inflammatory fecal cytokines reflect local inflammatory activity in UC and CD. Their use may be promising as non-invasive biomarkers of IBD activity

  • Algorithm for immunological examination of children with immune-dependent diseases to predict the effectiveness of biological therapy

    by Tatiana V. Radygina, Svetlana V. Petrichuk, Andrey P. Fisenko, Darya G. Kuptsova, Olga V. Kurbatova, Anton O. Anushenko, Leonid A. Opryatin, Luizat M. Abdullaeva, Ekaterina V. Freydlin, Alexander S. Potapov, et al.

    Introduction. The emergence of a wide range of genetically engineered biological products (GEBP) opens up opportunities for a personalized approach in the treatment of immune-dependent diseases. The development of methods for predicting the effectiveness of biological therapy for timely treatment correction is of particular relevance. Laboratory and clinical biomarkers are being studied.Materials and methods. A laboratory examination was conducted on 486 children aged of 3.5 to 18 years with inflammatory bowel diseases (IBD), 182 children with psoriasis (PS), and 147 children with multiple sclerosis (MS). The study included a set of quantitative and functional indicators: the content of basic (T, B, NK cells) and small populations of lymphocytes (Th17 lymphocytes, regulatory T cells (Treg), activated T helper cells), populations of memory T cells, populations of myeloid suppressor cells (MDSCs), Treg with CD39 ectonucleotidase expression, succinate dehydrogenase (SDH) activity in lymphocyte populations, and nuclear factor kB (NF-kB) activity in lymphocyte populations. The comparison group consisted of 100 conditionally healthy children of comparable age. The diagnostic and prognostic significance of immunological parameters and the level of threshold values (cut-off) were evaluated using the method of characteristic curves (ROC analysis).Results. A high probability of predicting (> 70%) the effect of GIBP therapy was obtained for the Th17/Treg index, regardless of the form of pathology and duration of therapy; for the absolute content of regulatory cells (Treg and MDSCs), regardless of the form of pathology during the maintenance course of GIBP; the activity of ADHD in Treg — in IBD and PS, regardless of the duration of therapy; the combination of ADHD activity in Treg and the Th17/Treg index in IBD, PS and MS, regardless of the duration of therapy; memory T cell subpopulations in IBD, PS and MS during the maintenance course; the relative Treg content with ectonucleotidase CD39 expression in IBD and MS after the induction course. Exceeding the threshold values for NF-κB levels in NK cells has been shown to predicts the activation of the inflammatory process in children with IBD, PS, and MS with a high probability (> 70%).Conclusion. A 2-stage algorithm for immunological examination of children with IBD, PS, and MS has been developed based on informative immunological indicators, which allow for a high probability of predicting the effect of biological therapy and the activity of the inflammatory process before the administration of GIBPs and during the maintenance course.Contribution: Radygina T.V., Petrichuk S.V. — research concept and design; Radygina T.V., Petrichuk S.V., Kuptsova D.G., Kurbatova O.V., Anushenko A.O., Opryatin L.A., Abdullaeva L.M., Freidlin E.V. — collection and processing of material; Radygina T.V., Petrichuk S.V. — writing the text; Fisenko A.P., Potapov A.S., Murashkin N.N., Kuzenkova L.M. — editing the text. All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.Acknowledgment. The study was supported by a state assignment from the Russian Ministry of Health, № 119013090093-2, 122040800220-9.Conflict of interest. The authors declare no conflict of interest.Received: November 10, 2025Accepted: November 27, 2025Published: December 25, 2025

  • Open Access

    The content of memory T-cells in children with immune-mediated inflammatory disease with varying effectiveness of biological therapy

    by Татьяна Вячеславовна Радыгина, Светлана Валентиновна Петричук, Darya G. Kuptsova, Ольга Владимировна Курбатова, Андрей Петрович Фисенко, Луизат Муслимовна Абдуллаева, Ekaterina V. Freydlin, Александр Сергеевич Потапов, Николай Николаевич Мурашкин, Людмила Михайловна Кузенкова, et al.

    Introduction. Immune memory is a tool of the adaptive immune system that allows it responding quickly and effectively to repeated contact with an antigen. The role of memory cell populations in the recurrence and progression of immune-dependent diseases is shown. Aim. To determine the trend in memory T-cell populations depending on the effectiveness of biological therapy (BT) in children with inflammatory bowel disease (IBD), multiple sclerosis (MS) and psoriasis (PS). Materials and methods. Four hundred fifty children with immunosuppressive diseases (ISD) were examined during different periods of administration of biological drugs: IBD — 162 children (infliximab /adalimumab), MS — 116 children (interferon β1α — IFNβ1α), PS — 172 children (adalimumab). The effectiveness of BT was assessed using clinical activity indices and functional methods. Lymphocyte immunophenotyping was performed by flow cytometry to determine populations of CD4+ and CD8+ memory T-cell: central (TCM), effector (TEM), and terminally differentiated (TEMRA). Statistical data processing was carried out in the Statistica 16.0 program, using the Mann–Whitney U-test, Spearman correlation analysis (p < 0.05). In the SPSS version 25 software, ROC analysis was performed in the efficiency–inefficiency separation model. Results. In all forms of pathology, changes in the content of memory T-cells have been established depending on the activity of inflammation. In IBD and PS patients, with an increase in the indices of disease activity, a decrease in the levels of CD4+ naive T-cells (TNAIVE) and an increase of TCM were detected. In MS patients with active foci, an MRI scan showed a decrease in the percentage of naive CD8+ T-cells (TcytNAIVE) and an increase in the population of CD8+ TEM. The content of TNAIVE populations decreased with age, and memory T-cells increased in patients with all the studied forms of pathology. In patients with BT efficacy, a high content of TNAIVE populations and a low content of TCM were found compared with the levels in patients with insufficient BT efficacy. Thresholds have been determined for IBD, MS, and PS patients, which make it possible to predict the effectiveness of BT. An increase in the levels of TNAIVE and TcytNAIVE makes it possible to predict the presence of a BT effect, an increase in the levels of TCM, CD4+ TEM, and CD8+ ТEMRA make it possible to predict the absence or insufficient effect of BT. Conclusion. The activity of the inflammatory process is reflected in the differentiation of populations of CD4+ and CD8+ memory T cells. With the effectiveness of BT, the number of TNAIVE increases with a decrease in the number of TCM and TEM in patients with immune-dependent diseases, regardless of the form of pathology and the drug used. Threshold values for memory T-cells populations make it possible to predict the effectiveness of BT.

  • Open Access

    The survival rate of biological therapy in immunosuppressive diseases in children

    by Татьяна Вячеславовна Радыгина, Светлана Валентиновна Петричук, Андрей Петрович Фисенко, Darya G. Kuptsova, Ольга Владимировна Курбатова, Луизат Муслимовна Абдуллаева, Ekaterina V. Freydlin, Александр Сергеевич Потапов, Николай Николаевич Мурашкин, Людмила Михайловна Кузенкова, et al.

    Genetically engineered biological preparations (GEBP) are successfully used in various immunosuppressive diseases. Despite the effectiveness of GEBP, some patients experience primary non-response, as well as loss of effect from therapy. There is a need to objectively assess the effect of the therapy for its timely correction. The aim of the work was to determine the survival rate of GIBP depending on the form of pathology, drug, age, and immune indices in children with Crohn’s disease (CD), ulcerative colitis (UC), psoriasis (PS), multiple sclerosis (MS). Materials and methods. Three hundred eighty three children (1394 observations) were examined in dynamics: 117 children with BC (treated by infliximab (IFX)/adalimumab (ADA), 83 children with UC (IFX/ADA), 87 children with PS (ADA), 96 children with PC (IFNβ1α) during the maintenance course therapy. Lymphocytes were immunophenotyped by flow cytometry with the determination of Treg (CD4+CD25highCD127low), Th17 lymphocytes (CD4+CD161+CD3+), succinate dehydrogenase (SDH) activity in Treg. Data processing was carried out using Statistica 16.0 application. Kaplan–Mayer survival curves are constructed. The significance of the differences between the groups was assessed using the Gehan–Wilcoxon criterion (p < 0.05). Results. The survival rate of biological therapy in CD patients on IFX therapy is significantly higher than in children with UC — 161 weeks versus 135 weeks. There was no difference in CBT on ADA therapy between patients with CD and UC. The IBT index depends on the age of the patients: on IFX therapy (159 weeks) the best indices were in CD patients over 12 years. Combination therapy improves the survival of TNF blockers in patients with IBD (azathioprine) and PS (methotrexate). The survival of GIBP is influenced by the ratio of effector and regulatory cells (Th17|Treg) and the functional activity of Treg (SDH activity). A decrease in IBD was revealed in patients with IBD, PS, and MS with an increase in the Th17/Treg index above the age norm and a decrease in the activity of SDH in Treg below the norm. Conclusion. The survival rate of biological therapy for immunosuppressive diseases in children depends on the form of pathology, the drug, the age of patients, previous therapy, combination therapy, as well as immune indices during the maintenance course. Monitoring of Th17/Treg and SDH activity in Treg may be an important laboratory criterion for the effectiveness of GIBP.

  • Open Access

    Levels of circulating cytokines in children with multiple sclerosis with different effectiveness of interferon therapy

    by T. V. Radygina, S. V. Petrichuk, O. V. Kurbatova, D. G. Kuptsova, A. P. Fisenko, E. L. Semikina, E. V. Freydlin, L. M. Abdullaeva, B. I. Bursagova

    Multiple sclerosis (MS) is a chronic, demyelinating disease that leads to disability. Understanding the etiology of MS contributes to the development of pathogenetic methods of treatment, and the search for informative biomarkers of the effectiveness of treatment will allow the patient to adjust therapy in time. The aim of this work was to determine informative cytokines and cytokine profiles to predict the effectiveness of IFN-β1a therapy in children with MS.Materials and methods. 66 children with MS aged 16 [14.2–17.5] years who are on INFß-1a therapy were examined: group 1 — patients with exacerbation of MS (with active foci of demyelination by MRI), n = 34; group 2 — patients in remission of MS (without active foci), n = 32. The content of cytokines in the blood serum of patients was assessed using the multiplex panel Human Th17 Magnetic Bead Panel.Results: There was a significant increase in cytokine concentrations in patients with exacerbation of MS compared with children in remission: IL5, IL6, IL9, IL12p70, IL17E/IL25, IL21, IL28A, GM-CSF, TNFß. Threshold values for IL9 (AUC = 0,785), IL6 (AUC = 0,750), TNFß (0,740), IL28A (AUC = 0,744) were obtained above which it is possible to predict an exacerbation of MS in patients: IL9 — 3.9 pg/ml (Sn — 70.6, Sp — 71.9), IL6 — 4.0 pg/ml (Sn — 70.6, Sp — 68.8), TNFß — 6.6 pg/ml (Sn — 70.6, Sp — 71.9), IL28A — 243.0 pg/ml (Sn — 70.6, Sp — 71.9). Cytokine profiles associated with T-lymphocytes and their functions were evaluated using z-score.Conclusions. For the first time, an increase in cytokine levels was demonstrated in children with active foci of demyelination compared to patients in remission of MS. An increase in proinflammatory cytokines and cytokine profiles associated with Th1 and Th17, as well as with Th2 and Th22 has been shown. The use of threshold values for IL9, IL6, TNFβ, IL28A will help predict the development of exacerbation in patients with MS.

  • Open Access

    Changes in cytokine complexes in children with autoimmune diseases with different effectiveness of their biological therapy

    by Татьяна Вячеславовна Радыгина, Андрей Петрович Фисенко, Светлана Валентиновна Петричук, Darya G. Kuptsova, Ольга Владимировна Курбатова, Ekaterina V. Freydlin, Александр Сергеевич Потапов, Николай Николаевич Мурашкин, Бэлла Ибрагимовна Бурсагова, Луизат Муслимовна Абдуллаева, et al.

    Introduction. Cytokines (CC) play an important pathogenetic role in the development of autoimmune diseases. Over the past decade, there has appeared a huge number of biological drugs that target certain cytokines. The main problem remains the choice of a suitable biological drug, as up to 40% of patients do not respond to treatment or become resistant to it. Aim: to identify informative cytokine complexes in children with psoriasis, MS, and IBD with different efficacy of biological therapy. Materials and methods. Two hundred eighty eight children with autoimmune diseases were examined against the background of supportive biological therapy. Patients were divided into groups of exacerbation and remission depending on the lesion area index PASI for psoriasis (PS), clinical activity indices PUCAI for ulcerative colitis (UC), PCDIA for Crohn’s disease (CD), by the pre­sence of foci of demyelination on MRI for patients with multiple sclerosis (MS). All patients underwent a study of 25 cytokines in serum samples using multiplex analysis (X-MAP technology). Results. In PS, MS, UC, and CD patients, an increase in pathogenetically significant cytokine profiles associated with cells (c) and functions (f) of M1 cells, Th1, Th2, Th17 was revealed in the exacerbation of diseases relative to the groups in remission. There was a significant decrease in the levels of cytokines and cytokine complexes in patients with MS relative to patients with PS, UC and CD, with the exception of cTh1. Threshold values of the level of cytokine complexes above which the development of an exacerbation of the disease can be expected were obtained: for PS — 1431.1 pg/ml (fTh22 — IL13 + Il22), for PC — 33.1 pg/ml (cTh1 — IFN-γ + IL12p70 + TNF-β + IL2), UC — 20.9 pg/ml (M1 — IL-1 + IL-6 + TNF-α), CD — 1986 pg/ml (fIL12 — IL12 + IL23 + IL27). Conclusion. To assess the effectiveness of biological therapy and to predict the condition of patients, it is possible to evaluate specific cytokine complexes for a specific pathology.


  • Open Access

    T helper subsets during the acute post-traumatic period in children

    by R. Sh. Zakirov, S. V. Petrichuk, Ekaterina V. Freidlyn, Daria G. Kuptsova, Olga G. Yanyushkina, Olga V. Karaseva, Купцова Дарья Геннадьевна

    Severe mechanical injury is among the main reasons of disability and mortality in pediatric patients. The imbalance between the states of inflammation and immune suppression during the critical period of post-traumatic injury bears an elevated risk for infectious complications and/or multiple organ failure. The present study aimed to determine the informative immunological criteria in order to evaluate severity and prognosis for clinical outcomes in children from the severe injury group (SInj, ISS 16, n = 87); mild/moderate injury group (MInj, ISS 16, n = 34), as based on assessment of helper T cells (Th) ratios, i.e., Th17/Treg, T127hi/ Treg, and Th17/T127hi. The patients with severe injuries were classified by their outcomes (favorable, n = 47; unfavorable, n = 40), presence of infectious complications (IC, n = 16) and the development of multiple organ failure (MOF, n = 11). Th ratios were studied on the 1st, 3rd, 5th, 7th, 14th day after injury. For the Sinj group, a pronounced increase of Th17/Treg ratio in the acute post-traumatic period with a decrease by 14 days was revealed. The indices of T127hi/Treg ratio on the first day for the patients from Minj group corresponded to the values of control group and significantly differed from patients with SInj in the 3rd to 5th day. There are different kinetics of Th subset ratio in peripheral blood of children with severe injuries over time in different groups, as well as with/without MOF, in presence, or absence of infectious complications and different clinical outcomes. Significant differences in T127hi/Treg ratio level were found in group with IC from 1st to 3rd day and from 7th to 14th day. Significant differences in Th17/Treg ratio level were found in IC group (7th day), in MOF group on 14th day post-injury. The patients with MOF had lower median concentrations of Th17/Treg and T127hi/Treg than patients without MOF. The results of the study indicate that the levels of Th17/Treg and T127hi/Treg ratio in children may be used to predict outcome of the traumatic disease and assess the risk of infectious complications and multiple organ dysfunction syndrome.

  • Open Access

    Role of myeloid-derived suppressor cells in prediction of the effectiveness of biologics in children with psoriasis

    by Daria G. Kuptsova, Tatyana V. Radygina, Ekaterina V. Freidlin, Olga V. Kurbatova, Nikolay N. Murashkin, Svetlana V. Petrichuk, Купцова Дарья Геннадьевна

    Psoriasis is a chronic inflammatory skin disease characterized by increased proliferation of epidermal cells, impaired keratinization, and an inflammatory reaction in the dermis due to activation of T-lymphocytes and synthesis of proinflammatory cytokines. Pathophysiology of psoriasis is associated not only with activation of proinflammatory reactions, but also with decreased anti-inflammatory functions of immunosuppressive cells. It is known that Treg, Breg and MDSCs do not perform their classical homeostatic functions in psoriasis. In recent years, there have been more and more cases of developing resistance to ongoing therapy with genetically engineered biological drugs (GEBD) in childhood, requiring replacement or discontinuation of the drug. The aim of our work was to estimate the content of MDSCs subpopulations and their functional activity in the peripheral blood of children with psoriasis at different effectiveness of biotherapeutic drugs. We examined 110 children with psoriasis vulgaris before the appointment of biologics, at 16 and 52 weeks of therapy with adalimumab, etanercept and ustikinumab, aged 6 to 18 years. Сomparison group consisted of 34 healthy children. The effectiveness of therapy was assessed by the achievement of PASI 75 by one year of therapy. Contents of myeloid-derived suppressor cells (MDSCs) and their subpopulations, and the activity of arginase-1 were assessed by multicolor flow cytometry. An increased content of MDSCs was found in children with psoriasis against the comparison group (p = 0.000). Analysis of the effectiveness of biologics in children with psoriasis, according to PASI, showed a significant reduction in disease severity in the group of patients with good effect, both at week 16 of therapy (p = 0.000) and by one year (p = 0.017). In the group of patients with good effect of biological therapy, percentage of total MDSCs population was higher, both before start of treatment and by 52nd week of therapy (p 0.01). Children with psoriasis showed increased immunosuppressive function of MDSCs by arginase-1 activity versus the comparison group (p = 0.000). The arginase-1 activity in patients with psoriasis at the stage of disease regression (PASI 10) was significantly increased relative to children in progressive stage of psoriasis (PASI10; p = 0.001). Thus, the content of MDSCs and their suppressive activity in children with psoriasis is an informative efficiency predictor of the biological drugs. Fading of biotherapy effect after the induction course is accompanied by decreased number of MDSCs and their functional activity.

  • Open Access

    Nuclear transcription factor kB (NF-kB) activity in lymphocyte populations in children with Wilson-Konovalov disease

    by O. V. Kurbatova, S. V. Petrichuk, D. G. Kuptsova, G. B. Movsisyan, T. V. Radygina, A. D. Komarova, A. O. Anushenko, E. V. Freidlin, E. L. Semikina, A. S. Potapov, et al.

    Wilson's disease (WD) is a rare hereditary disease caused by a deficiency of the ATF7B transporter. The accumulation of copper can cause damage to organs and cells, mainly the liver. Copper exposure can modulate cytokine synthesis through molecular and cellular signaling pathways, including the nuclear transcription factor NF-kB pathway. NF-kB is the main regulator of inflammation and cell death, acts as a central link between liver damage, fibrosis and hepatocellular carcinoma. An excess of NF-kB-dependent cytokine response stimulates inflammatory reactions, but excessive inhibition of NF-kB can negatively affect the viability of hepatocytes. Method of flow cytometry with visualization — Amnis ImageStreamX allows to evaluate the activity of NF-kB (% of activated cells in cell populations). The aim: to evaluate the activity of NF-kB in lymphocyte populations in children with WD disease. Immunophenotyping of lymphocytes and assessment of the level of translocation of NF-kB were performed in 52 children with WD and in 25 children of comparison group. The mass concentration of copper in daily urine was determined by atomic absorption method using the AAnalyst 800 spectrometer. In children with WD, the content of cells with NF-kB translocation varied from 5 to 90% depending on the lymphocyte population; the highest level was detected in B cells — 57.5 (37-68) %. A significant difference in distributions of the number of cells with NF-kB translocation between WD and healthy children was shown (F-criterion, p < 0.01). In most cases, children with WD are characterized by a decrease in the activity of NF-kB in populations of B cells (in 43% of cases), T helper cells (48%), T cytotoxic (44%) and Th17 lymphocytes (41%). In children with WD, the concentration of copper varied from 9.7 to 2582 mcg/day, Me = 616 (210-1173). A direct relationship was obtained between the copper content in urine and the level of translocation of NF-kB in B lymphocytes, r = 0.34, p = 0.016. The activity of the NF-kB correlates with biochemical markers of the severity of liver damage (ALT, AST, GGT) and with copper content in urine. The study of the NF-kB signaling pathway seems promising for a better understanding of the pathogenetic mechanisms of the formation of inflammation and liver fibrosis in children with WD.


  • Open Access

    Dynamics of T helper subpopulations in the critical period of severe injury in children

    by R. Sh. Zakirov, S. V. Petrichuk, E. V. Freidlyn, D. G. Kuptsova, O. G. Yanyushkina, O. V. Karaseva

    Severe mechanical injury is one of the main reasons behind children’s disability and mortality. Severe injury induces a complex host immune response to tissue injury, a parallel pro- and anti-inflammatory state, bearing an elevated risk for infectious complications (IC) and/or multiple organ failure (MOF). This study aimed to determine the informative immunological criteria of traumatic injury severity and prognosis outcome in children (severe injury group (SInj, ISS ≥ 16), n = 87; mild/moderate injury group (MInj, ISS < 16), n = 34) based on the assessment of absolute cell count (abs) and percentage of such T helper subpopulations as regulatory T lymphocytes – CD4+CD127lowCD25high(Treg), Th17 lymphocytes – CD4+CD161+ and CD4+CD127higtCD25high T cells(T127hi) in severe injury cases grouped by the outcome (favorable, n = 47; unfavorable, n = 40) and depending on IC (n = 16) and the development of MOF (n = 11) on the 1st, 3d , 5th, 7th, 14th day after injury. The control group was comprised of 80 apparently healthy children comparable in age and sex. An inverse relationship between severity of injury, degree of blood loss and outcome of injury was revealed with the abs of all Th populations, but for Th abs and Treg abs the most significant correlation was found (Spearman’s R ≤ -0,70, p < 0.00001). For SInj group, a pronounced decrease of Th abs, Treg abs, T127hi abs and Th17 abs, in the acute post-traumatic period with an increase to 14 days was revealed. The values of in the first day for indicators of patients with MInj group correspond to the values of control group and significantly differ from SInj group. There are different kinetics of percentage Th subpopulations in peripheral blood of children with severe injuries. The Th17%CD4+ and T127hi%CD4+ significant increase in 1st-3d and 3d -7th days after injury respectively in comparation with сontrol and MInj groups. There were no differences between groups in terms of Treg%CD4+. The lower-level Treg abs in trauma patients admitted to the ICU is significantly associated with develop the infectious complications and outcome of trauma. The Th17 abs is significantly reduced in 3-7th days after the injury in the SInj group with MOF. The results of the study indicate that in children levels of Treg, T127hi and Th17 is significantly associated with severity of injury and may be used to predict outcome of trauma and assess the risk of IC and MOF.